New Obicetrapib cholesterol-lowering pill cuts heart attacks, strokes risk

Groundbreaking Study Reveals Obicetrapib’s Dual Benefits A new cholesterol-lowering pill, Obicetrapib, may revolutionize treatment for individuals at high risk of heart attacks and strokes. In a significant international study led by Monash University, researchers discovered that this once-daily oral medication effectively lowers

1 40 41 42 43 44 130